887139-06-2 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(4-bromo-2-fluorophenyl)-N-methylmethanamine is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique structure, which includes a bromine and fluorine atom on the phenyl ring, allows for the creation of a diverse range of pharmaceutical compounds with different therapeutic properties.
Used in Research Chemicals:
In the field of research chemicals, 1-(4-bromo-2-fluorophenyl)-N-methylmethanamine serves as a valuable compound for studying the structure-activity relationships of various drugs and neurotransmitters. Its presence in these studies aids in understanding the interactions between these molecules and their target receptors, ultimately contributing to the development of more effective and targeted therapeutic agents.
Used in Drug Development:
1-(4-broMo-2-fluorophenyl)-N-MethylMethanaMine is also utilized in the development of new drugs, particularly in the areas of neuroscience and psychiatry. Its structural features make it a promising candidate for the design of novel molecules with potential applications in the treatment of neurological and psychiatric disorders.
Used in Chemical Research:
1-(4-bromo-2-fluorophenyl)-N-methylmethanamine is employed as a research tool in chemical research, where it helps scientists explore new reaction pathways and develop innovative synthetic methods. Its unique structural elements facilitate the investigation of various chemical transformations and the synthesis of complex molecular architectures.
Check Digit Verification of cas no
The CAS Registry Mumber 887139-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,1,3 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 887139-06:
(8*8)+(7*8)+(6*7)+(5*1)+(4*3)+(3*9)+(2*0)+(1*6)=212
212 % 10 = 2
So 887139-06-2 is a valid CAS Registry Number.
887139-06-2Relevant academic research and scientific papers
NOVEL ANTIBIOTICS AND METHODS OF USING SAME
-
Page/Page column 69-70, (2018/05/16)
The present invention includes novel 3,6-diazabicyclo[3.1.1]heptane antibiotic compounds and any salts or solvates thereof. The present invention further includes methods of preparing such compounds, and methods of treating bacterial infection in a subjec
SUBSTITUTED TRICYCLIC 1,4-BENZODIAZEPINONE DERIVATIVES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS
-
Page/Page column 228-229, (2017/05/28)
The present invention provides novel tricyclic 1,4-benzodiazepinone derivatives of the general formula (I) and pharmaceutical compositions containing them. Moreover, the compounds of formula (I) and the pharmaceutical compositions containing them are provided for use in the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions, and/or conditions which can be affected by alteration of glutamate level or signalling in mammals. The tricyclic 1,4-benzodiazepinone derivatives of formula (I) can act as modulators of nervous system receptors sensitive to glutamate, in particular as modulators of metabotropic glutamate receptors (mGluRs), which makes them particularly suitable for the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders. The present invention further provides tricyclic 1,4-benzodiazepinone derivatives of formula (I) that are modulators of metabotropic glutamate receptors (mGluRs), particularly positive allosteric modulators of mGluRs, and more specifically positive allosteric modulators of mGluR3. (I)
